Diltiazem

This classification denotes a calcium channel blocker with the molecular formula C22H26N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EE92BBP03H, chemically known as 3-acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one but generally known as diltiazem, which bears US NIH Compound Identifier 3076. European Medicines Agency schedules Diltiazem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07148MIG. The term DILTIAZEM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules diltiazem in its Anatomical Therapeutic Chemical (ATC) Classification. DILTIAZEM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diltiazem under HS 29349990 and SITC 51579. As of Q4 2014, DILTIAZEM remains the US FDA Preferred Term for this commodity. Diltiazem bears US NLM identifiers UMLS ID C0012373 and NCI Concept Code C61725. SMILES: S1C(C(OC(=O)C)C(=O)N(CCN(C)C)c2c1cccc2)c1ccc(OC)cc1.